313 related articles for article (PubMed ID: 35399942)
1. A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy.
Sun Y; Kong L; Zhang AH; Han Y; Sun H; Yan GL; Wang XJ
Front Endocrinol (Lausanne); 2022; 13():858012. PubMed ID: 35399942
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics in Diabetic Retinopathy: From Potential Biomarkers to Molecular Basis of Oxidative Stress.
Jian Q; Wu Y; Zhang F
Cells; 2022 Sep; 11(19):. PubMed ID: 36230967
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of Diabetic Retinopathy.
Liew G; Lei Z; Tan G; Joachim N; Ho IV; Wong TY; Mitchell P; Gopinath B; Crossett B
Curr Diab Rep; 2017 Sep; 17(11):102. PubMed ID: 28940103
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in Diabetic Retinopathy: A Systematic Review.
Hou XW; Wang Y; Pan CW
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):4. PubMed ID: 34347011
[TBL] [Abstract][Full Text] [Related]
5. Vitreous metabolomics profiling of proliferative diabetic retinopathy.
Tomita Y; Cagnone G; Fu Z; Cakir B; Kotoda Y; Asakage M; Wakabayashi Y; Hellström A; Joyal JS; Talukdar S; Smith LEH; Usui Y
Diabetologia; 2021 Jan; 64(1):70-82. PubMed ID: 33099660
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characterization of diabetic retinopathy: An
Jin H; Zhu B; Liu X; Jin J; Zou H
J Pharm Biomed Anal; 2019 Sep; 174():414-421. PubMed ID: 31212142
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor.
Wang H; Fang J; Chen F; Sun Q; Xu X; Lin SH; Liu K
Acta Diabetol; 2020 Jan; 57(1):41-51. PubMed ID: 31089930
[TBL] [Abstract][Full Text] [Related]
8. Ferrous ascorbate as a potential biomarker for diabetic retinopathy: a vitreous humour metabolomics study.
Liu J; Liu S; Hui P; Teng S; Xie J; Sun Y
BMC Ophthalmol; 2024 Jun; 24(1):270. PubMed ID: 38914965
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators.
Cordero-Pérez P; Sánchez-Martínez C; García-Hernández PA; Saucedo AL
Nefrologia (Engl Ed); 2020; 40(6):585-596. PubMed ID: 33036786
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Du X; Yang L; Kong L; Sun Y; Shen K; Cai Y; Sun H; Zhang B; Guo S; Zhang A; Wang X
Front Endocrinol (Lausanne); 2022; 13():1037164. PubMed ID: 36387907
[TBL] [Abstract][Full Text] [Related]
11. Urine metabolomics study of Bushen Huoxue Prescription on diabetic retinopathy rats by UPLC-Q-exactive Orbitrap-MS.
Wang X; Li Y; Xie M; Deng L; Zhang M; Xie X
Biomed Chromatogr; 2020 Apr; 34(4):e4792. PubMed ID: 31907953
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics window into diabetic complications.
Wu T; Qiao S; Shi C; Wang S; Ji G
J Diabetes Investig; 2018 Mar; 9(2):244-255. PubMed ID: 28779528
[TBL] [Abstract][Full Text] [Related]
13.
Dmuchowska DA; Pietrowska K; Krasnicki P; Grochowski ET; Mariak Z; Kretowski A; Ciborowski M
J Ocul Pharmacol Ther; 2020 Oct; 36(8):580-581. PubMed ID: 32833545
[No Abstract] [Full Text] [Related]
14. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms.
Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J
J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics in diabetic complications.
Filla LA; Edwards JL
Mol Biosyst; 2016 Apr; 12(4):1090-105. PubMed ID: 26891794
[TBL] [Abstract][Full Text] [Related]
16. Effect of the ethyl acetate extract of Sophora flavescens Aiton on diabetic retinopathy based on untargeted retinal metabolomics.
Luo Y; Zhao K; Li Z; Gao Y; Lin M; Li Y; Wang S; Liu Y; Chen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1198():123233. PubMed ID: 35395445
[TBL] [Abstract][Full Text] [Related]
17. LC-QTOF-MS-based targeted metabolomics of arginine-creatine metabolic pathway-related compounds in plasma: application to identify potential biomarkers in pediatric chronic kidney disease.
Benito S; Sánchez A; Unceta N; Andrade F; Aldámiz-Echevarria L; Goicolea MA; Barrio RJ
Anal Bioanal Chem; 2016 Jan; 408(3):747-60. PubMed ID: 26537926
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Biochemical Composition of Vitreous of Eyes of Diabetic Patients Using Proton Magnetic Resonance Spectroscopy.
Simsek IB; Artunay O
Curr Eye Res; 2017 May; 42(5):754-758. PubMed ID: 27897443
[TBL] [Abstract][Full Text] [Related]
19. Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy.
Sumarriva K; Uppal K; Ma C; Herren DJ; Wang Y; Chocron IM; Warden C; Mitchell SL; Burgess LG; Goodale MP; Osborn MP; Ferreira AJ; Law JC; Cherney EF; Jones DP; Brantley MA
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3119-3126. PubMed ID: 31323682
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine.
Li X; Luo X; Lu X; Duan J; Xu G
Mol Biosyst; 2011 Jul; 7(7):2228-37. PubMed ID: 21559540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
